Clase Tratamiento de la Epilepsia

Clase Tratamiento de la Epilepsia

Introduction to Antiepileptic Drugs

Overview of the Session

  • The session focuses on antiepileptic drugs and their role in managing epilepsy.
  • The speaker expresses admiration for notable figures in the field, including Dr. Charlotte, Dr. Lilia Rocha, Dr. Silvia Cochain, and Dr. Iris Martínez, highlighting their contributions to epilepsy research and education.

Understanding Antiepileptic Terminology

  • The term "antiepileptic drugs" has evolved; previously referred to as "anti-crisis medications," it now emphasizes modifying seizure behavior rather than combating epilepsy itself.
  • Approximately 1-2% of the population requires medication for epilepsy treatment, emphasizing its prevalence and importance in healthcare.

Mechanism and Importance of Antiepileptic Drugs

Treatment Approach

  • Antiepileptic drugs are considered symptomatic treatments that control epileptic seizures based on the type of seizure and syndrome involved.
  • A visual representation illustrates how these medications can stabilize electrical activity in the brain during seizures when taken consistently; discontinuation can lead to increased seizure risk.

Limitations of Antiepileptic Medications

  • These medications do not cure epilepsy but significantly reduce the likelihood of seizures occurring again if adhered to properly.
  • Key pharmacokinetic properties, drug interactions, side effects, and toxicity are crucial factors influencing patient adherence to treatment plans—30%-40% may struggle with adherence due to these issues.

Efficacy and Adherence Challenges

Research Findings

  • Studies by the American Academy of Neurology (2004 & 2018) indicate no significant difference in seizure control among new antiepileptic drugs compared to older ones; however, newer options show better tolerability which aids adherence rates.
  • Proper selection of antiepileptic medication can ensure adequate control in 50%-70% of cases when initiated correctly after a first unprovoked high-risk seizure event known as epilepsy.

Early Intervention Significance

  • Early treatment is critical as it reduces recurrence rates within two years following an initial unprovoked seizure episode; absence of treatment may worsen conditions leading to more frequent seizures or drug resistance issues.

Monotherapy vs Polytherapy

Initial Treatment Strategy

  • The recommended approach is starting with monotherapy (a single antiepileptic drug) before considering additional medications if necessary; this strategy aims for optimal management while minimizing adverse effects associated with multiple drugs.

New Drug Characteristics

  • Newer antiepileptics are noted for improved efficacy, better tolerability, and reduced toxicity according to reports from relevant medical associations like the American Academy of Neurology and the American Epilepsy Society.

This structured summary provides a comprehensive overview while linking back directly to specific timestamps for further exploration or clarification on each point discussed during the session.

Case Study of Epileptic Seizures

Introduction to the Patient Case

  • The case discusses a woman who experienced her first generalized tonic-clonic seizure at age 55, with prior episodes of epigastric discomfort lasting seconds to minutes.
  • She reported headaches following these episodes and had three to four such events monthly until recent months when they ceased. A family video showed her in a dissociative state during an episode.

Clinical Background

  • The patient has a history of traumatic brain injury six years prior, which caused temporary loss of alertness but did not require hospitalization or further intervention. No significant gynecological history was noted.
  • Imaging studies (MRI) were normal; however, an EEG indicated left temporal dysfunction, raising questions about the nature of her seizures.

Diagnostic Considerations

  • The discussion emphasizes determining whether the patient's condition is epilepsy based on the characteristics of her seizures and associated symptoms. It highlights the importance of recognizing focal versus generalized seizures.
  • Three types of seizures are identified: simple focal without consciousness alteration, complex focal with consciousness alteration, and generalized tonic-clonic seizures as part of an epileptic syndrome known as mesial temporal lobe epilepsy.

Risk Factors for Recurrence

  • Key risk factors for seizure recurrence include:
  • Previous cerebral insult (e.g., trauma).
  • Abnormal EEG findings.
  • Significant neuroimaging abnormalities.
  • Nighttime seizures (not applicable in this case).

These factors suggest a high risk for recurrent seizures despite only one reported event thus far.

Treatment Decision

  • Given the presence of risk factors and previous symptoms indicating potential focal onset, treatment is deemed necessary for this patient’s condition, confirming a diagnosis of epilepsy due to both generalized and focal features observed during her episodes.

Second Case Overview

Introduction to Second Patient Case

  • A second case involves a male patient who began experiencing seizures at age 15 after feeling altered thoughts while sitting with friends; he later woke up in the hospital post-seizure with tongue biting noted by his mother.

Description of Seizure Events

Epilepsy Diagnosis and Treatment Insights

Patient Case Overview

  • A 20-year-old male patient was treated with carbamazepine (200 mg every eight hours) after experiencing a seizure. An EEG showed generalized slow spike-wave activity.
  • Eight months post-treatment, the patient reported involuntary movements resembling tics, which he could not control, leading to dropped objects.
  • The patient described episodes of loss of alertness and sudden jerks in his shoulders and head, indicating possible myoclonic jerks.

Seizure Types and Frequency

  • The young man experienced myoclonus twice weekly and generalized tonic-clonic seizures at age 18. He also reported absence-like episodes occurring monthly.
  • Myoclonic jerks were primarily observed in the morning and triggered by sleep deprivation. His medication regimen included phenytoin and carbamazepine.

Classification of Epileptic Seizures

  • Different types of seizures were identified: focal seizures, myoclonias, and absences. The patient's condition is classified as idiopathic generalized epilepsy with absence seizures.
  • Specific epileptic syndrome diagnosed is juvenile myoclonic epilepsy based on the characteristics of the seizures presented.

Antiepileptic Drug Selection

  • When treating patients with multiple seizure types, it’s crucial to select appropriate antiepileptic drugs (AEDs). There are over 20 AED options available today.
  • AED classifications include first-generation (older drugs) versus second/third-generation (newer drugs), with newer options like lamotrigine and levetiracetam showing fewer side effects.

Evidence-Based Treatment Recommendations

  • Current evidence suggests that both patients have distinct types of epilepsy requiring tailored treatment approaches based on their specific seizure characteristics.
  • Studies indicate that for focal seizures, oxcarbazepine and lamotrigine are preferred; for generalized seizures, valproate is often recommended but should be used cautiously in women of childbearing age due to potential risks.

Efficacy of Antiepileptic Medications

  • Research from 2000 to 2010 highlighted lamotrigine's effectiveness for both focal and generalized seizures alongside valproate as a primary choice for generalizations.
  • A meta-analysis from 2017 confirmed carbamazepine, lamotrigine, and levetiracetam as top choices for focal seizures while recommending valproate for generalized cases but noting its limitations in certain populations.

Initial Treatment Strategies

  • Initial treatment typically involves monotherapy aimed at achieving seizure freedom; approximately 50% success rate expected within one year post-diagnosis.

Epilepsy Treatment Insights

Understanding the Timeframe for Crisis Freedom

  • The process of achieving crisis freedom with optimal antiepileptic dosage can take between three to six months, with 30-40% of patients facing difficulties in this regard.

Goals in Epilepsy Management

  • Clear objectives are essential when treating epilepsy; physicians must aim for monotherapy and strive to achieve freedom from seizures while minimizing adverse effects.

Importance of Patient Support and Self-Care

  • Effective management requires collaboration with patients and their families, focusing on avoiding triggers such as alcohol, insomnia, and stress. Realistic expectations about treatment outcomes are crucial since antiepileptic drugs do not cure epilepsy but manage it over the long term.

Medication Adherence and Consequences

  • Approximately 70% of patients can control seizures with medication; however, missed doses can lead to serious consequences regarding seizure control. Strategies must be established to ensure adherence to treatment plans.

Choosing the Right Antiepileptic Drug

  • Selecting an appropriate antiepileptic drug involves considering factors like the type of seizure, mechanism of action, efficacy in trials, pharmacokinetics, and potential side effects. This choice is critical for effective management.

Types of Seizures and Corresponding Treatments

Focal Seizures: Identification and Treatment Options

  • Focal seizures may present as autonomic symptoms or consciousness alterations; medications like carbamazepine or levetiracetam are recommended as first-line treatments for these types of seizures.

Generalized Seizures: First-Line Medications

  • For generalized tonic-clonic seizures or myoclonic seizures, valproate is considered a first-line treatment option due to its broad efficacy across different seizure types including absence seizures.

Considerations for Female Patients

  • Special considerations should be made for female patients who may be affected by certain medications during their reproductive years; valproate's implications need careful evaluation in this context.

Broad vs Narrow Spectrum Medications

Overview of Antiepileptic Medications

Broad-Spectrum Antiepileptics

  • Medications like valproate, levetiracetam, and lamotrigine are effective for controlling a wide range of seizures.

Narrow-Spectrum Antiepileptics

  • Carbamazepine is highlighted as highly effective for focal seizures but not suitable for absence or myoclonic seizures, as seen in case studies.

Efficacy in Specific Cases

  • Carbamazepine is beneficial for focal seizures but worsens absence and myoclonic seizures, indicating its limited spectrum of effectiveness.

Mechanism of Action Considerations

  • When adding an antiepileptic drug (AED), it’s crucial to choose one with a different mechanism of action to avoid increased side effects and ineffective seizure control.

Importance of Drug Interactions

  • Understanding pharmacokinetics and drug interactions is vital since many AEDs undergo hepatic processing, which can lead to competition among drugs affecting efficacy.

Favorable Antiepileptic Options

Preferred Medications with Fewer Interactions

  • Levetiracetam, gabapentin, pregabalin, topiramate, lamotrigine, oxcarbazepine are noted for having fewer drug interactions and being more favorable in complex cases.

Special Considerations for Comorbidities

  • In patients with multiple medications or comorbidities, selecting AEDs with minimal interactions becomes essential to ensure safety and efficacy.

Tailoring Treatment Based on Patient Characteristics

Adverse Effects Awareness

  • It’s important to consider potential adverse effects when choosing AEDs; this helps tailor treatment based on individual patient characteristics such as asthma or allergies.

Managing Coexisting Conditions

  • For patients with conditions like asthma or liver disease (e.g., cirrhosis), safer options include levetiracetam and pregabalin due to their lower risk profiles.

Mental Health Considerations

Understanding Antiepileptic Drug Selection

Factors Influencing Medication Choice

  • The selection of medications for patients with sleep disorders, such as obstructive sleep apnea, often focuses on those that stimulate mood and alertness, like Motrin.
  • Weight changes can be influenced by antiepileptic drugs; thus, in cases of obesity or metabolic syndrome, it is crucial to choose medications that may aid in weight reduction, such as Topiramate.
  • Identifying the type of epileptic seizure is fundamental for determining the appropriate first-line antiepileptic drug.

Comorbidities and Their Impact

  • It’s essential to consider comorbid conditions when selecting antiepileptics; for instance, a premenopausal woman may experience adverse effects from certain medications while benefiting from others like Levetiracetam.
  • A comprehensive analysis of both benefits and potential worsening conditions helps in isolating unsuitable antiepileptics.

Collaborative Efforts in Epilepsy Care

Video description

Clase impartida por Dra. Wendy Sanchez